|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
ATE269295T1
(de)
|
1998-04-17 |
2004-07-15 |
Parker Hughes Inst |
Btk inhibitoren und verfahren zur identifizierung und verwendung
|
|
WO2000007991A1
(en)
*
|
1998-08-04 |
2000-02-17 |
Astrazeneca Ab |
Amide derivatives useful as inhibitors of the production of cytokines
|
|
ATE254105T1
(de)
*
|
1998-09-25 |
2003-11-15 |
Astrazeneca Ab |
Benzamid-derivate und ihre verwendung als cytokine inhibitoren
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US7132438B2
(en)
|
2001-10-09 |
2006-11-07 |
Amgen Inc. |
Benzimidazole derivatives
|
|
AU2003262642B2
(en)
|
2002-08-14 |
2010-06-17 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
US8030336B2
(en)
*
|
2002-12-13 |
2011-10-04 |
Ym Biosciences Australia Pty Ltd |
Nicotinamide-based kinase inhibitors
|
|
TW200616974A
(en)
*
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
CN101128454A
(zh)
*
|
2004-12-22 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
用作抗癌药物的吡啶羧酰胺衍生物
|
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
|
WO2006081172A2
(en)
|
2005-01-26 |
2006-08-03 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
AU2006278627B2
(en)
|
2005-08-08 |
2011-08-18 |
Janssen Pharmaceutica, N.V. |
Thiazolopyrimidine kinase inhibitors
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
ES2604539T3
(es)
*
|
2005-11-14 |
2017-03-07 |
Genentech, Inc. |
Inhibidores de tipo bisamida de la señalización hedgehog
|
|
US20070155746A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
US20090312396A1
(en)
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
DK2526933T3
(en)
|
2006-09-22 |
2015-05-18 |
Pharmacyclics Inc |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2008144253A1
(en)
*
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
TW200911798A
(en)
|
2007-08-02 |
2009-03-16 |
Amgen Inc |
PI3 kinase modulators and methods of use
|
|
PL2508523T5
(pl)
|
2007-10-23 |
2020-08-10 |
Teva Pharmaceutical Industries Ltd. |
Odmiany polimorficzne dasatynibu i sposób ich wytwarzania
|
|
EP2222166B9
(en)
|
2007-12-10 |
2012-11-07 |
Concert Pharmaceuticals Inc. |
Heterocyclic kinase inhibitors
|
|
CA2723237A1
(en)
|
2008-05-06 |
2009-11-12 |
Peter A. Blomgren |
Substituted amides, method of making, and use as btk inhibitors
|
|
AU2009280679B2
(en)
*
|
2008-08-13 |
2012-07-26 |
Mitsui Chemicals Crop & Life Solutions, Inc. |
Amide derivative, pest control agent containing the amide derivative and use of the pest control agent
|
|
AU2009289378A1
(en)
|
2008-09-02 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Novel benzamides, production thereof, and use thereof as medicaments
|
|
US8598174B2
(en)
|
2008-11-12 |
2013-12-03 |
Genetech, Inc. |
Pyridazinones, method of making, and method of use thereof
|
|
AU2010289353B2
(en)
|
2009-09-03 |
2016-12-08 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYL-BTK INHIBITORS
|
|
WO2011090738A2
(en)
|
2009-12-29 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
CN110003219A
(zh)
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
|
JP2014500254A
(ja)
|
2010-11-09 |
2014-01-09 |
セルゾーム リミティッド |
Ｔｙｋ２阻害剤としてのピリジン化合物およびそのアザ類似体
|
|
US20140080810A1
(en)
|
2010-11-15 |
2014-03-20 |
Exelixis, Inc. |
Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
|
|
LT2714677T
(lt)
*
|
2011-05-23 |
2018-12-10 |
Merck Patent Gmbh |
Piridino ir pirazino dariniai
|
|
MX354412B
(es)
|
2011-06-10 |
2018-03-05 |
Merck Patent Gmbh |
Composiciones y metodos para la produccion de compuestos de pirimidina con actividad inhibidora de tirosina cinasa de bruton.
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2013050261A1
(en)
*
|
2011-10-03 |
2013-04-11 |
Syngenta Participations Ag |
Insecticidal 2-methoxybenzamide derivatives
|
|
HK1201065A1
(en)
|
2011-10-04 |
2015-08-21 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of pi3k
|
|
EP2773639B1
(en)
|
2011-11-03 |
2017-04-26 |
F. Hoffmann-La Roche AG |
Alkylated piperazine compounds as inhibitors of btk activity
|
|
US9382239B2
(en)
|
2011-11-17 |
2016-07-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-terminal kinase (JNK)
|
|
EP2790705B1
(en)
|
2011-12-15 |
2017-12-06 |
Novartis AG |
Use of inhibitors of the activity or function of pi3k
|
|
CN103405429A
(zh)
*
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
WO2015069287A1
(en)
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
EP3079683A4
(en)
|
2013-12-13 |
2017-12-20 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
|
CA2932353A1
(en)
|
2013-12-13 |
2015-06-18 |
Steven P. Treon |
Methods to treat lymphoplasmacytic lymphoma
|
|
EP3715346B1
(en)
|
2014-10-22 |
2024-01-03 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|